Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy-Reference-Cited by-同舟云学术

Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy

Published:2012-01-26 Issue:16 Volume:118 Page:4053-4062
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zafarana Gaetano,Ishkanian Adrian S.,Malloff Chad A.,Locke Jennifer A.,Sykes Jenna,Thoms John,Lam Wan L.,Squire Jeremy A.,Yoshimoto Maisa,Ramnarine Varune Rohan,Meng Alice,Ahmed Omar,Jurisca Igor,Milosevic Michael,Pintilie Melania,van der Kwast Theo,Bristow Robert G.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26729/fullpdf

Reference34 articles.

1. Optimizing patient selection for dose escalation techniques using the prostate-specific antigen level, biopsy Gleason score, and clinical T-stage;D'Amico;Int J Radiat Oncol Biol Phys.,1999

2. Optimal treatment of intermediate-risk prostate carcinoma with radiotherapy: clinical and translational issues;Nichol;Cancer.,2005

3. NCCN clinical practice guidelines in oncology: prostate cancer;Mohler;J Natl Compr Canc Netw.,2010

4. Predictive models in external beam radiotherapy for clinically localized prostate cancer;Roach;Cancer.,2009

5. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis;Lapointe;Cancer Res.,2007

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells;Nature Communications;2024-09-03

2. From microscopes to molecules: The evolution of prostate cancer diagnostics;Cytojournal;2024-08-29

3. PTEN Loss Is Associated with Adverse Outcomes in the Setting of Salvage Radiation Therapy;European Urology Oncology;2024-07

4. Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility;British Journal of Cancer;2023-11-09

5. PTEN loss in intraductal carcinoma of the prostate has low incidence in Japanese patients;Pathology International;2023-08-23